SELEGILINE FOR NEUROLEPTIC-INDUCED PARKINSONISM

[11] NEUROPATHOLOGICAL CHANGES IN THE CAUDATE-NUCLEUS ELICITED BY MPTP AND THEIR PREVENTION BY MONOAMINE-OXIDASE INHIBITION [J]. BRAIN RESEARCH, 1989, 499 (02) : 393 - 396

[12] ELECTROPHYSIOLOGICAL INTERACTIONS BETWEEN HALOPERIDOL AND REDUCED HALOPERIDOL, AND DOPAMINE, NOREPINEPHRINE AND PHENCYCLIDINE IN RAT-BRAIN [J]. NEUROPHARMACOLOGY, 1985, 24 (05) : 375 - 379

[13] KNOLL J, 1986, MOVEMENT DISORDERS

[14] PATHO-PHYSIOLOGY OF EXTRAPYRAMIDAL SIDE-EFFECTS OF NEUROLEPTIC DRUGS [J]. PSYCHOLOGICAL MEDICINE, 1980, 10 (01) : 55 - 72

[15] MINDHAM RC, 1976, PSYCHOL MED, V6, P28

[16] POSSIBLE MECHANISM OF ACTION OF DEPRENYL IN PARKINSONISM [J]. LANCET, 1990, 336 (8708) : 183 - 183

[17] PERENYI A, 1983, PHARMACOPSYCHIATRIA, V16, P143, DOI 10.1055/s-2007-1019488

[18] SHEPPARD MA, 1967, AM J PSYCHIAT, V123, P886

[19] SHOULSON I, 1989, NEW ENGL J MED, V321, P1364

[20] Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11

[11] NEUROPATHOLOGICAL CHANGES IN THE CAUDATE-NUCLEUS ELICITED BY MPTP AND THEIR PREVENTION BY MONOAMINE-OXIDASE INHIBITION [J]. BRAIN RESEARCH, 1989, 499 (02) : 393 - 396

[12] ELECTROPHYSIOLOGICAL INTERACTIONS BETWEEN HALOPERIDOL AND REDUCED HALOPERIDOL, AND DOPAMINE, NOREPINEPHRINE AND PHENCYCLIDINE IN RAT-BRAIN [J]. NEUROPHARMACOLOGY, 1985, 24 (05) : 375 - 379

[13] KNOLL J, 1986, MOVEMENT DISORDERS

[14] PATHO-PHYSIOLOGY OF EXTRAPYRAMIDAL SIDE-EFFECTS OF NEUROLEPTIC DRUGS [J]. PSYCHOLOGICAL MEDICINE, 1980, 10 (01) : 55 - 72

[15] MINDHAM RC, 1976, PSYCHOL MED, V6, P28

[16] POSSIBLE MECHANISM OF ACTION OF DEPRENYL IN PARKINSONISM [J]. LANCET, 1990, 336 (8708) : 183 - 183

[17] PERENYI A, 1983, PHARMACOPSYCHIATRIA, V16, P143, DOI 10.1055/s-2007-1019488

[18] SHEPPARD MA, 1967, AM J PSYCHIAT, V123, P886

[19] SHOULSON I, 1989, NEW ENGL J MED, V321, P1364

[20] Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11